Oxford Biomedica (LON:OXB) Stock Passes Below 200-Day Moving Average of $210.46

Oxford Biomedica plc (LON:OXB) crossed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of GBX 210.46 ($2.66) and traded as low as GBX 192.35 ($2.43). Oxford Biomedica shares last traded at GBX 197.20 ($2.49), with a volume of 129,030 shares changing hands.

Wall Street Analyst Weigh In

Separately, Numis Securities restated a “hold” rating and issued a GBX 180 ($2.27) target price on shares of Oxford Biomedica in a research note on Wednesday, March 20th.

Oxford Biomedica Trading Up 1.3 %

The company has a market cap of £197.12 million, a P/E ratio of -308.13 and a beta of 1.00. The company has a quick ratio of 1.67, a current ratio of 3.32 and a debt-to-equity ratio of 57.10. The firm’s 50-day moving average price is GBX 183 and its 200-day moving average price is GBX 210.46.

Oxford Biomedica Company Profile

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.